BioCentury
ARTICLE | Clinical News

Formoterol Modulite regulatory update

February 2, 2009 8:00 AM UTC

EMEA's CHMP recommended against use of Chiesi's formoterol 12 µg to treat asthma in children ages 5-12 years because efficacy could not be demonstrated in the age group. The formoterol hydrofluoroalka...